Researchers evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the AZALEA-TIMI 71 Study. The trial ...
Patients with atrial fibrillation are typically prescribed an anticoagulant, or blood thinner, to reduce the risk of stroke, but many may discontinue them or never receive a prescription due to ...
in 2025 that could impact how you pay for your medications — and how much you pay. Here’s what you need to know as we kick off the new year. 1. Out-of-pocket drug costs will be capped at $2,000 The ...
Sydney researchers have found that Levofloxacin substantially reduces risk of drug-resistant tuberculosis. This discovery offers new hope against a disease that infects more than 400,000 people ...
The National Agency for Food and Drug Administration and Control (NAFDAC) has alerted Nigerians, including healthcare providers, about a counterfeit cancer treatment drug, Phesgo 600mg/600mg/10ml ...
And it’s annoying. It’s scary when you get stuck in Afib because there isn’t anything you can do.” These days, Beatty takes medications to help control his Afib when he feels it coming on ...
TORONTO — The Ontario government is protecting the safety of children and families while improving access to recovery and treatment services by approving the transition of nine drug injection sites ...
In a disclaimer, GoodRx noted that the list was created by prioritizing "first-in-class medications and vaccines that are expected to have a significant impact on human health." "This was defined ...
Last March, for example, she sponsored a successful ballot measure to require drug screening and treatment for people receiving county welfare benefits who are suspected of illicit drug use.
President-elect Trump’s plan to enact heavy tariffs on certain imports could affect the prices and availability of pharmaceutical drugs in the ... for at-home dialysis treatment.
Several major pharmaceutical companies, including Pfizer, Bristol Myers Squibb and Sanofi, are set to raise prices on more than 250 branded medications in the U.S. starting Jan. 1, 2025 ...